Methyl-CpG-binding domain 3 inhibits stemness of pancreatic cancer cells via Hippo signaling

Volume: 393, Issue: 1, Pages: 112091 - 112091
Published: Aug 1, 2020
Abstract
Methyl-CpG-binding domain 3 (MBD3), as an induced stem cells reprogramming barrier, has an abnormal expression in various prevalent malignancies. However, in pancreatic cancer cell stemness, the roles of MBD3 remain unclear. In our study, the effects of MBD3 were investigated on the proliferation, stemness and the underlying mechanism in pancreatic cancer cells. Firstly, MBD3 knockdown was proved to promote proliferation and sphere formation of...
Paper Details
Title
Methyl-CpG-binding domain 3 inhibits stemness of pancreatic cancer cells via Hippo signaling
Published Date
Aug 1, 2020
Volume
393
Issue
1
Pages
112091 - 112091
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.